Medication info

Uni-Infusion Injection (L-Aspartic Acid-L-Ornithine)

Prescription medicationSolution
Ingredient · strength
L-Ornithine-L-Aspartate›500mg / 1mL
Manufacturer / importer
한국유니온제약(주)
Appearance
[For domestic use, for export 1] Colorless to light yellow solution contained in a brown ampoule
Packaging
5 ampoules/box [(10 milliliters/ampoule)], 10 ampoules/box [(10 milliliters/ampoule)], 25 ampoules/box [(10 milliliters/ampoule)]
Approval status
Active

MFDS item code 200101499 · Notified 2001.04.26

Summary

Main use
Detoxification treatment for severe liver disease (hepatic encephalopathy)
Who uses it
Adults
Adult dosage
For hepatic encephalopathy (including pre-coma and coma), L-Aspartic Acid-L-Ornithine can be mixed up to 40 g (8 ampoules) in appropriate intravenous fluids and administered as a drip infusion daily. The dosage may be adjusted appropriately according to the symptoms.

Ingredients

Manufacturer
한국유니온제약(주)

Efficacy & effects

Detoxification treatment for severe liver disease (hepatic encephalopathy)

  • Detoxification for severe liver disease
  • hepatic encephalopathy
  • pre-coma
  • coma
View approved original text

This medication is used to treat hepatic encephalopathy caused by severe liver disease, which includes symptoms ranging from pre-coma to coma. Hepatic encephalopathy is a condition in which liver function is severely impaired, leading to toxins affecting the brain. This medicine helps improve these symptoms and aids in the recovery of the patient's condition. Therefore, it is used for the treatment of hepatic encephalopathy in patients with severe liver disease.

Dosage and Administration

Adult dosage

For hepatic encephalopathy (including pre-coma and coma), L-Aspartic Acid-L-Ornithine can be mixed up to 40 g (8 ampoules) in appropriate intravenous fluids and administered as a drip infusion daily. The dosage may be adjusted appropriately according to the symptoms.

Precautions

This medication is in a glass ampoule and can have glass fragments enter the solution when opening the container, so it should be cut carefully to minimize glass particles. Extra caution should be taken especially when used for children or the elderly. This medication should not be used in patients with certain conditions. For example, it should not be administered to patients with lactate acidosis, methanol poisoning, sensitivities to fructose or sorbitol, certain enzyme deficiencies, and severely impaired renal function. Additionally, this medication contains sodium metabisulfite, which may cause allergic reactions. Patients with asthma or those who are sensitive to sulfites may experience severe allergic reactions, so it should be used with caution. When using this medication, there may occasionally be a feeling of warmth in the back of the head or nausea, and gastrointestinal discomfort or vomiting may occur. In case of high dosages, urea levels in the blood or urine should be monitored to check the body condition. Patients with weakened liver function should adjust the infusion speed to reduce discomfort or vomiting. This medication should be administered slowly intravenously, as rapid infusion may lead to side effects. When storing it, it should be kept in a secure place out of reach of children and should not be transferred from its original container to another container. This will help maintain the quality of the medication and prevent misuse.

Side effects and when to seek care immediately

Serious side effects

Asthma attack

Mild side effects

  • Warm sensation in the back of the head
  • nausea
  • gastrointestinal discomfort
  • vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to light, so it should be stored in a light-protected tightly sealed container. Additionally, the medication should be stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication over a long period.

Appearance and packaging

Appearance

[For domestic use, for export 1] Colorless to light yellow solution contained in a brown ampoule

Package unit

5 ampoules/box [(10 milliliters/ampoule)], 10 ampoules/box [(10 milliliters/ampoule)], 25 ampoules/box [(10 milliliters/ampoule)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.